EGFR/ErbB-2 inhibitor-1

CAS No. 1135150-79-6

EGFR/ErbB-2 inhibitor-1( —— )

Catalog No. M37253 CAS No. 1135150-79-6

EGFR/ErbB-2 inhibitor-1 is a selective ErbB2/HER2 inhibitor that effectively blocks ErbB2 and HER2 signaling.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 296 Get Quote
5MG 459 Get Quote
10MG 657 Get Quote
25MG 994 Get Quote
50MG 1371 Get Quote
100MG 1773 Get Quote
500MG 3537 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    EGFR/ErbB-2 inhibitor-1
  • Note
    Research use only, not for human use.
  • Brief Description
    EGFR/ErbB-2 inhibitor-1 is a selective ErbB2/HER2 inhibitor that effectively blocks ErbB2 and HER2 signaling.
  • Description
    EGFR/ErbB-2 inhibitor-1 is a ErbB2/HER2 inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1135150-79-6
  • Formula Weight
    467.97
  • Molecular Formula
    C23H15ClFN3OS2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    FC1=CC=CC(=C1)COC2=CC=C(C=C2Cl)NC=3N=CN=C4SC(=CC43)C=5SC=CC5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Rheault TR, et al. Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors. Bioorg Med Chem Lett. 2009 Feb 1;19(3):817-20.?
molnova catalog
related products
  • WHI-P154

    WHI-P154 is a potent JAK3 inhibitor with IC50 of 1.8 μM, no activity against JAK1 or JAK2, also inhibits EGFR, Src, Abl, VEGFR and MAPK, prevents Stat3, but not Stat5 phosphorylation.

  • CCF642

    CCF642 is a novel PDI-inhibiting compound with antimyeloma activity.

  • SU5402

    SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGF-Rβ, respectively.